OPKO HealthMEX:OPK 53 Beneish M-Score is -2.88 as of Jul. 12, 2026. GuruFocus rates MEX:OPK with a GF Score™ of 53/100 and a GF Value™ of MXN19.16 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 195 Medical Diagnostics & Research companies, OPKO Health ranks better than 67.69% on this metric.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Good Sign:
Beneish M-Score -2.88 no higher than -1.78, which implies that the company is unlikely to be a manipulator.
The historical rank and industry rank for OPKO Health's Beneish M-Score or its related term are showing as below:
MEX:OPK'
s Beneish M-Score Range Over the Past 10 Years
Min: -3.42 Med: -2.73 Max: 5.1
Current: -2.88
During the past 13 years, the highest Beneish M-Score of OPKO Health was 5.10. The lowest was -3.42. And the median was -2.73.
OPKO Health Beneish M-Score Related Terms
OPKO Health Beneish M-Score Historical Data
* Premium members only.
The historical data trend for OPKO Health's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:OPK vs PSNL, CDNA, CSTL: Beneish M-Score Comparison
For the Diagnostics & Research subindustry, OPKO Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OPKO Health Beneish M-Score vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where OPKO Health's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of OPKO Health for today is based on a combination of the following eight different indices:
M
=
-4.84
+
0.92 * DSRI
+
0.528 * GMI
+
0.404 * AQI
+
0.892 * SGI
+
0.115 * DEPI
=
-4.84
+
0.92 * 0.9451
+
0.528 * 0.8921
+
0.404 * 1.0844
+
0.892 * 0.7798
+
0.115 * 1.0041
-
0.172 * SGAI
+
4.679 * TATA
-
0.327 * LVGI
-
0.172 * 0.8611
+
4.679 * -0.062695
-
0.327 * 0.9031
=
-2.99
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI
=
(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))
/
(Depreciation_t / (Depreciaton_t + PPE_t))
=
(1900.133 / (1900.133 + 2434.812))
/
(1653.913 / (1653.913 + 2134.801))
=
0.438329
/
0.436537
=
1.0041
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA
=
(IncomefromContinuingOperations_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(NetIncome_t - NonOperatingIncome_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(-3950.084 - 1170.391
-
-3021.24)
/
33483.045
=
-0.062695
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
OPKO Health has a M-score of -2.99 suggests that the company is unlikely to be a manipulator.
OPKO Health (MEX:OPK) has a Beneish M-Score of -2.88 as of Jul. 12, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on OPKO Health and its competitors. According to the industry distribution chart, OPKO Health ranks #63 out of 195 companies in the Medical Diagnostics & Research industry, placing it in the top 32.3%.
Is OPKO Health's Beneish M-Score too high?
OPKO Health's current Beneish M-Score is -2.88. Based on the distribution chart, OPKO Health ranks #63 out of 195 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, OPKO Health has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OPKO Health's Beneish M-Score compare to PSNL and CDNA?
According to the Medical Diagnostics & Research industry distribution chart, OPKO Health ranks #63 out of 195 companies for Beneish M-Score. This puts OPKO Health in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Diagnostics & Research company?
A good Beneish M-Score depends on the Medical Diagnostics & Research industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on OPKO Health and its competitors. OPKO Health's current Beneish M-Score is -2.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OPKO Health stock overvalued right now?
Based on GuruFocus' analysis, OPKO Health (MEX:OPK) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN19.16, compared to a current price of MXN26.20 — trading 36.7% above its estimated fair value. The current Beneish M-Score is -2.88. OPKO Health's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For OPKO Health (MEX:OPK), the current Beneish M-Score is -2.88 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OPKO Health (MEX:OPK) Overvalued in 2026?
Based on GuruFocus' analysis, OPKO Health stock appears to be overvalued.
The current stock price of MXN26.20 is trading 36.7% above its estimated GF Value™ of MXN19.16.
GuruFocus considers OPKO Health to be Significantly Overvalued.
Key valuation signals for MEX:OPK:
Beneish M-Score: -2.88
GF Value™: MXN19.16 vs. price of MXN26.20 (36.7% above fair value)
No single metric tells the full story. See the MEX:OPK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
53GF Score
Get the complete analysis for MEX:OPK
Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:OPK has been successfully added to your 
